Further study demonstrated that NS1 potently inhibits cell growth in 3D cultures of K-Ras mutated cells and blocks the oncogenic K-Ras-driven tumor growth in vivo, providing proof of concept for targeting the α4–α5 dimerization interface as an approach to inhibit Ras-driven tumorigenesis [107]. This evidence concerns the gene KRAS and neoplasm.